Our President, Dr Sugo, will be giving a presentation at Bio Japan 2025 (October 8-10, 2025, at Pacifico Yokohama).
At Bio Japan 2025 (October 8-10, 2025, Pacifico Yokohama), our President, Dr. Shugo, will appear in the exhibitor presentation “The Evolution of Drug Discovery Modalities Powered by Innovation and Convergence 1” on Wednesday, October 8, starting at 3:30 PM. For more details, please see here.
We identified a potent antiviral oligonucleotide against the SFTS (Severe fever with thrombocytopenia syndrome) virus jointly with the Japan Institute for Health Security and the National Institute of Infectious Diseases.
In collaboration with Japan Institute for Health Security National Institute of Infectious Diseases, we have conducted basic research for the development of silencing nucleic acid drugs rationally designed based on the SFTS virus genome sequence. Through the second screening process using in vitro SFTS virus infection system, we have identified a series of oligonucleotide sequences […]
We have started a new contract service using digital PCR.
Digital PCR can be used to analyze samples that are difficult to analyze using conventional real-time PCR, such as rare mutations or quantitative methods that do not use calibration curves. Please contact us if you would like to try digital PCR on a small sample. Click here to contact us
We will exhibit our contract genome editing services at the 5th Pharmalabo EXPO Osaka (February 25-27, 2025 at Intex Osaka).
We will have a booth for our contract genome editing service at the 5th Pharmalabo EXPO Osaka to be held at Intex Osaka from February 25th to 27th.
Our company has been listed in the "Japanese Life Science Startup List" edited and managed by the Japan Bioindustry Association and NPO Kinki Bio-Industry Development Organization.
We are pleased to announce that our company has been listed in the "Japanese Life Science Startup List," jointly created and managed by the Japan Bioindustry Association and NPO Kinki Bio-Industry Development Organization. Click here for the list.
Our President, Dr Sugo, will be a lecturer at the webinar 'Fundamentals of genome editing technology and key points for its use in drug discovery research' organised by Research and Development Support Center CO.,LTD.
We are pleased to inform you that Dr Sugo, our company's president, will be a lecturer at the above web-only seminar (date and time: 12 June 2024 (Wed), 13:00-16:00), organised by Research and Development Support Center CO., LTD. Click here for more details of the lecture and registration for the seminar.
Our business was introduced in ThermoFisher Scientific's life science magazine "NEXT" No.67.
We are pleased to inform you that Thermo Fisher Scientific's life science magazine "NEXT" No.67, digitally published on October 25, 2023, features an introduction to our business titled "Diversified development of contract services and collaborative research with our unique genome editing and nucleic acid delivery technologies" Click here for the digital issue in Japanese.